BioSpace News Archive

Starlight Cardiovascular, Inc. announced that it has been awarded a Small Business Innovation Research (SBIR) Phase II grant from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) to advance development of its Ductus Arteriosus Stent System.

Medtronic plc announced Cosmo Pharmaceuticals and NVIDIA plan to integrate NVIDIA’s AI technologies into the GI Genius™ intelligent endoscopy module — the first FDA-cleared, AI-assisted colonoscopy tool to help physicians detect polyps that can lead to colorectal cancer.

The U.S. Food and Drug Administration (FDA) has cleared expanded Indications for Use for screening with FibroScan®, the non-invasive liver management technology by Echosens.

Ascentage Pharma today announced its annual results for the full year 2022.

The Society of Toxicology (SOT) Computational Toxicology Specialty Section has awarded Gradient’s abstract one of the Top 10 abstracts for the Computational Toxicology Specialty Section of its 2023 Annual Meeting.

Qrons Inc. (OTCQB:QRON) today announced that it has filed an International Patent Application at the International Bureau, for inventions of Therapeutic Polypseudorotaxane Hydrogels.

Regencor Inc. a life sciences company that is focused on the development of therapies for treatment of cardiovascular disease, announced it has appointed Philip Janiak, Ph.D. and Ken Mahaffey, M.D. to its Scientific Advisory Board.

Pragma Bio developed a first-of-its-kind-map of chemicals designed by nature, housed in humans, and linked to immune-related health outcomes

Nyxoah SA, a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea, reported financial and operating results for the fourth quarter and full year 2022.

Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today reported financial results for the fourth quarter and full year ended December 31, 2022.